Heron Capital
Venture capital fund dedicated to investing in mid and growth stage companies focused on the life sciences, including.
Heron Capital Home Investor Portal Contact Us ABOUT US THE HERON TEAM MEET THE TEAM ADVISORY BOARD PORTFOLIO INVESTMENT CRITERIA NEWS Untitled Document Greg Maurer brings a diverse set of business and legal skills to Heron Capital Equity Partners. Prior to forming Heron Capital, Mr. Maurer worked as a corporate attorney at Schiff Hardin, L.L.P. in Chicago, Illinois... Read more about Greg Maurer. See the entire Heron Capital Team. NeoChord is a venture backed medical device company that has developed a proprietary device which allows mitral valve repair to be performed on a beating heart through a 2 to 3 inch incision between the ribs in patients with severe mitral valve regurgitation. In contrast, most mitral valve repair procedures are performed through a 3 to 10 inch chest incision... View Our Portfolio Alliqua BioMedical, Inc. Announces Closing of Celleration, Inc. Acquisition June 1, 2015 AirXpanders Announces Initial Public Offering in AustraliaMay 26, 2015 AirXpanders Announces Initial Public Offering in AustraliaMay 26, 2015 Attendees Honor Scale Computing with Three XCellence Awards at the 2015 Midsize Enterprise Summit EastMay 14, 2015 Privacy Information © Copyright 2015 Heron Capital